Notícias · Recifes

Dual-mobility hip replacement implant can lower dislocation risk by 70%

A new type of hip replacement implant reduces the risk of joint dislocation after surgery by 70%, according to a new study involving 1,600 patients across 44 hospitals in Sweden and the UK, published in The Lancet. The new implant consists of a small ball encased in a much larger

Admin Recifes 15/07/2026 1

Patients in Hawai'i spent $230M+ on out-of-state cancer care in 2021–2023, study finds

A new study led by researchers at the University of Hawaiʻi Cancer Center found that at least $230 million was spent on cancer care delivered outside Hawaiʻi between 2021 and 2023, highlighting the significant financial impact of geographic isolation on patients and the health ca

Admin Recifes 15/07/2026 1

New tumor map identifies high-risk B-cell lymphoma standard therapy may miss

Researchers led by Universitätsmedizin Frankfurt and Goethe University Frankfurt have identified how particularly aggressive forms of lymphoma can be recognized. By combining genetic and proteomic analyses, the scientists identified biological characteristics of tumors, particula

Admin Recifes 15/07/2026 1

AI tool improves prediction of who will respond to cancer immunotherapy drugs

Cancer immunotherapy drugs known as immune checkpoint inhibitors (ICIs) can be miracle drugs for cancer patients, curing some and turning deadly disease into a manageable chronic condition in others. But these drugs work for only a subset of patients, with few indications why—a k

Admin Recifes 15/07/2026 2

Common brain cancer mutation changes DNA shape to drive progression, exposing therapeutic

A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common genetic alterations in glioma rewires the cancer cell genome to fuel tumor progression, suggesting a potential new therapeutic strategy for patients with ATR

Admin Recifes 15/07/2026 2

Genetic information helps predict the onset and progression of glaucoma

Glaucoma is the leading cause of irreversible visual impairment worldwide. Because the disease often progresses without symptoms for years, many patients are diagnosed only after permanent damage to the optic nerve has already occurred. Earlier detection through targeted screenin

Admin Recifes 15/07/2026 2

Repurposed cancer drug rapidly eased rare autoimmune neuropathy in two patients

An interdisciplinary team at Jena University Hospital achieved a surprisingly rapid and significant improvement in two patients with an autoimmune peripheral nervous system disorder. The team administered teclistamab, a drug originally developed for multiple myeloma, and reported

Admin Recifes 15/07/2026 2

Editing AI mistakes can cost doctors time when writing to patients

Errors and irrelevant details mean physicians may spend more time editing AI-drafted responses than it would take to write them, a large study of an online patient portal shows. Artificial intelligence is spreading rapidly in health care, with the goal of streamlining critical bu

Admin Recifes 15/07/2026 2

AI test predicts breast cancer recurrence in hours, not weeks, across 3,500 patients

In recent years, notable advances have been made in diagnosing and treating breast cancer. However, its recurrence continues to plague thousands, deepening the need to find ways to better predict the likelihood of its return.

Admin Recifes 15/07/2026 2

Biomarker-guided care to improve antidepressant response rates and reduce trial-and-error

For millions of people living with depression, finding an effective treatment can feel like a long and uncertain journey. Patients often spend months trying different medications, enduring side effects and persistent symptoms while waiting to discover whether a prescription will

Admin Recifes 15/07/2026 2

Researchers discover treatable cause of severe anemia associated with a cancer therapy

Researchers at the Mount Sinai Tisch Cancer Center have identified a previously underrecognized folate deficiency that may cause severe anemia in some patients receiving PARP inhibitors, a widely used class of targeted cancer therapies. Their findings, published in the latest iss

Admin Recifes 15/07/2026 2

Brain tumor vaccine links mutation targeting to eight-year survival gains

A novel vaccination strategy against certain malignant brain tumors could fundamentally improve treatment for patients. Researchers from the German Cancer Research Center (DKFZ), Mannheim University Medical Center, Heidelberg University Hospital and numerous partner institutions

Admin Recifes 15/07/2026 2

Acompanhe as Notícias da Recifes